Will T-cell therapy for cancer ever be a standard of care?

被引：11

作者：

Brenner, M. K. ^{[1
]}

机构：

[1] Baylor Coll Med, Methodist Hosp, Texas Childrens Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA

来源：

CANCER GENE THERAPY | 2012年 / 19卷 / 12期

关键词：

cancer; commercialization; T-cell therapy; METASTATIC MELANOMA; COMPLETE RESPONSES; ANTITUMOR-ACTIVITY; SAFETY SWITCH; ADVERSE EVENT; LEUKEMIA; TRANSPLANTATION; IMMUNOTHERAPY; LYMPHOCYTES; PERSISTENCE;

D O I：

10.1038/cgt.2012.74

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 [微生物学]; 090105 [作物生产系统与生态工程];

摘要：

Cellular therapies for cancer are showing increasing efficacy but their introduction as a 'standard of care' for these disorders is hampered by technical, regulatory and financial concerns. This review identifies some of the major problems and suggests potential solutions.

引用

页码：818 / 821

页数：4

共 35 条

[1]

Advances in graft-versus-host disease biology and therapy [J].

Blazar, Bruce R. ;

Murphy, William J. ;

Abedi, Mehrdad .

NATURE REVIEWS IMMUNOLOGY, 2012, 12 (06) :443-458

[2]

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer [J].

Bollard, Catherine M. ;

Gottschalk, Stephen ;

Leen, Ann M. ;

Weiss, Heidi ;

Straathof, Karin C. ;

Carrum, George ;

Khalil, Mariam ;

Wu, Meng-fen ;

Huls, M. Helen ;

Chang, Chung-Che ;

Gresik, M. Victoria ;

Gee, Adrian P. ;

Brenner, Malcolm K. ;

Rooney, Cliona M. ;

Heslop, Helen E. .

BLOOD, 2007, 110 (08) :2838-2845

[3]

Adapting a transforming growth factor β-related tumor protection strategy to enhance antitumor immunity [J].

Bollard, CM ;

Rössig, C ;

Calonge, MJ ;

Huls, MH ;

Wagner, HJ ;

Massague, J ;

Brenner, MK ;

Heslop, HE ;

Rooney, CM .

BLOOD, 2002, 99 (09) :3179-3187

[4]

Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical Trial [J].

Brentjens, Renier ;

Yeh, Raymond ;

Bernal, Yvette ;

Riviere, Isabelle ;

Sadelain, Michel .

MOLECULAR THERAPY, 2010, 18 (04) :666-668

[5]

PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine [J].

Cheever, Martin A. ;

Higano, Celestia S. .

CLINICAL CANCER RESEARCH, 2011, 17 (11) :3520-3526

[6]

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study [J].

Ciceri, Fabio ;

Bonini, Chiara ;

Stanghellini, Maria Teresa Lupo ;

Bondanza, Attilio ;

Traversari, Catia ;

Salomoni, Monica ;

Turchetto, Lucia ;

Colombi, Scialini ;

Bernardi, Massimo ;

Peccatori, Jacopo ;

Pescarollo, Alessandra ;

Servida, Paolo ;

Magnani, Zulma ;

Perna, Serena K. ;

Valtolina, Veronica ;

Crippa, Fulvio ;

Callegaro, Luciano ;

Spoldi, Elena ;

Crocchiolo, Roberto ;

Fleischhauer, Katharina ;

Ponzoni, Maurilio ;

Vago, Luca ;

Rossini, Silvano ;

Santoro, Armando ;

Todisco, Elisabetta ;

Apperley, Jane ;

Olavarria, Eduardo ;

Slavin, Shimon ;

Weissinger, Eva M. ;

Ganser, Arnold ;

Stadler, Michael ;

Yannaki, Evangelia ;

Fassas, Athanasios ;

Anagnostopoulos, Achilles ;

Bregni, Marco ;

Stampino, Corrado Gallo ;

Bruzzi, Paolo ;

Bordignon, Claudio .

LANCET ONCOLOGY, 2009, 10 (05) :489-500

[7]

Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes [J].

Comoli, P ;

Pedrazzoli, P ;

Maccario, R ;

Basso, S ;

Carminati, O ;

Labirio, M ;

Schiavo, R ;

Secondino, S ;

Frasson, C ;

Perotti, C ;

Moroni, M ;

Locatelli, F ;

Siena, S .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) :8942-8949

[8]

Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience [J].

Cruz, Conrad Russell ;

Hanley, Patrick J. ;

Liu, Hao ;

Torrano, Vicky ;

Lin, Yu-Feng ;

Arce, James A. ;

Gottschalk, Stephen ;

Savoldo, Barbara ;

Dotti, Gianpietro ;

Louis, Chrystal U. ;

Leen, Ann M. ;

Gee, Adrian P. ;

Rooney, Cliona M. ;

Brenner, Malcolm K. ;

Bollard, Catherine M. ;

Heslop, Helen E. .

CYTOTHERAPY, 2010, 12 (06) :743-749

[9]

Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy [J].

Di Stasi, Antonio ;

Tey, Siok-Keen ;

Dotti, Gianpietro ;

Fujita, Yuriko ;

Kennedy-Nasser, Alana ;

Martinez, Caridad ;

Straathof, Karin ;

Liu, Enli ;

Durett, April G. ;

Grilley, Bambi ;

Liu, Hao ;

Cruz, Conrad R. ;

Savoldo, Barbara ;

Gee, Adrian P. ;

Schindler, John ;

Krance, Robert A. ;

Heslop, Helen E. ;

Spencer, David M. ;

Rooney, Cliona M. ;

Brenner, Malcolm K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (18) :1673-1683

[10]

Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma [J].

Gerdemann, Ulrike ;

Katari, Usha ;

Christin, Anne S. ;

Cruz, Conrad R. ;

Tripic, Tamara ;

Rousseau, Alexandra ;

Gottschalk, Stephen M. ;

Savoldo, Barbara ;

Vera, Juan F. ;

Heslop, Helen E. ;

Brenner, Malcolm K. ;

Bollard, Catherine M. ;

Rooney, Cliona M. ;

Leen, Ann M. .

MOLECULAR THERAPY, 2011, 19 (12) :2258-2268

← 1 2 3 4 →